Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CENTRAL: Bevacizumab + FOLFIRI in Advanced Colorectal Cancer
NCT01853813Phase 2Completed
- Sponsor
- Fondazione Giscad per la Ricerca sui Tumori
- Start
- May 2013
- Primary completion
- May 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in colorectal cancer (CRC), sponsored by Fondazione Giscad per la Ricerca sui Tumori. Started May 2013; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01853813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01853813.